Wash. Admin. Code § 246-101-101
Table HC-1 (Conditions Notifiable by Health Care Providers and Health Care Facilities)
Notifiable Condition (Agent) | Laboratory Confirmation Required Before Submitting Case Report | Time Frame for Notification from Identification of a Case | Who Must Be Notified | Who Must Report: Health Care Providers (Providers) or Health Care Facilities (Facilities) |
Acquired immunodeficiency syndrome (AIDS) | Within 3 business days | DOH (for facilities) and LHJ (for providers) | Both | |
Amebic meningitis | Immediately | LHJ | Both | |
Anaplasmosis | Within 3 business days | LHJ | Both | |
Anthrax (Bacillus anthracis and confirmed Bacillus cereus biovar anthracis only - Do not report all Bacillus cereus ) | Yes | Immediately | LHJ | Both |
Arboviral disease (acute disease only) including, but not limited to: Chikungunya Dengue Eastern and western equine encephalitis Japanese encephalitis La Crosse encephalitis Powassan virus infection St. Louis encephalitis West Nile virus infection Zika virus infection See also "Yellow fever" | Within 3 business days | LHJ | Both | |
Asthma, occupational | Within 30 days | Washington state department of labor and industries (L&I) | Both | |
Babesiosis | Within 3 business days | LHJ | Both | |
Baylisascariasis | Within 24 hours | LHJ | Both | |
Birth defects - Abdominal wall defects (inclusive of gastroschisis and omphalocele) | Within 30 days | DOH | facilities | |
Birth defects - Autism spectrum disorders | Within 30 days | DOH | Both | |
Birth defects - Cerebral palsy | Within 30 days | DOH | Both | |
Birth defects - Down syndrome | Within 30 days | DOH | facilities | |
Birth defects - Alcohol related birth defects | Within 30 days | DOH | Both | |
Birth defects - Hypospadias | Within 30 days | DOH | facilities | |
Birth defects - Limb reductions | Within 30 days | DOH | facilities | |
Birth defects - Neural tube defects (inclusive of anencephaly and spina bifida) | Within 30 days | DOH | facilities | |
Birth defects - Oral clefts (inclusive of cleft lip with/without cleft palate) | Within 30 days | DOH | facilities | |
Blood lead level RST results (See WAC 246-101-200 ) | Providers and facilities performing blood lead level RST shall report as a laboratory and comply with the requirements of WAC 246-101-201 through 246-101-230. | |||
Botulism, foodborne, infant, and wound | Immediately | LHJ | Both | |
Brucellosis | Within 24 hours | LHJ | Both | |
Campylobacteriosis | Within 3 business days | LHJ | Both | |
Cancer (See chapter 246-102 WAC ) | ||||
Candida auris infection or colonization | Within 24 hours | LHJ | Both | |
Carbapenem-resistant Enterobacteria-ceae infections limited to: Klebsiella species E. coli Enterobacter species | Yes | Within 3 business days | LHJ | Both |
Chagas disease | Within 3 business days | LHJ | Both | |
Chancroid | Within 3 business days | LHJ | Both | |
Chlamydia trachomatis infection | Yes | Within 3 business days | LHJ | Both |
Cholera (Vibrio cholerae O1 or O139) | Yes | Immediately | LHJ | Both |
Coccidioidomycosis | Within 3 business days | LHJ | Both | |
Coronavirus infection (severe communicable) SARS-associated coronavirus MERS-associated coronavirus Novel coronavirus (COVID-19) | Yes | Immediately | LHJ | Both |
Coronavirus infection (severe communicable) Novel coronavirus (COVID-19) RST results (See WAC 246-101-200 ) | Providers and facilities performing Novel coronavirus (COVID-19) RST shall report as a laboratory and comply with the requirements of WAC 246-101-201 through 246-101-230. | |||
Cryptococcus gattii or undifferentiated Cryptococcus species (i.e., Cryptococcus not identified as C. neoformans ) | Yes | Within 3 business days | LHJ | Both |
Cryptosporidiosis | Within 3 business days | LHJ | Both | |
Cyclosporiasis | Within 3 business days | LHJ | Both | |
Cysticercosis | Within 3 business days | LHJ | Both | |
Diphtheria | Immediately | LHJ | Both | |
Domoic acid poisoning | Immediately | LHJ | Both | |
E. coli (See "Shiga toxin-producing E. coli" ) | ||||
Echinococcosis | Within 3 business days | LHJ | Both | |
Ehrlichiosis | Within 3 business days | LHJ | Both | |
Giardiasis | Within 3 business days | LHJ | Both | |
Glanders (Burkholderia mallei ) | Yes | Immediately | LHJ | Both |
Gonorrhea | Within 3 business days | LHJ | Both | |
Granuloma inguinale | Within 3 business days | LHJ | Both | |
Gunshot wounds (nonfatal) | Within 30 days | DOH | facilities | |
Haemophilus influenzae (invasive disease, children under 5 years of age) | Yes | Immediately | LHJ | Both |
Hantaviral infection | Within 24 hours | LHJ | Both | |
Hepatitis A (acute infection) | Yes | Within 24 hours | LHJ | Both |
Hepatitis B (acute infection) | Yes | Within 24 hours | LHJ | Both |
Hepatitis B, report pregnancy in hepatitis B virus infected patients (including carriers) | Yes | Within 3 business days | LHJ | Both |
Hepatitis B (chronic infection) - Initial diagnosis, and previously unreported prevalent cases | Yes | Within 3 business days | LHJ | Both |
Hepatitis B (perinatal) - Initial diagnosis, and previously unreported cases | Yes | Within 3 business days | LHJ | Both |
Hepatitis C (acute infection) | Yes | Within 24 hours | LHJ | Both |
Hepatitis C (acute infection) RST results (See WAC 246-101-200 ) | Providers and facilities performing hepatitis C (acute infection) RST shall report as a laboratory and comply with the requirements of WAC 246-101-201 through 246-101-230. | |||
Hepatitis C (chronic infection) | Yes | Within 3 business days | LHJ | Both |
Hepatitis C (perinatal) - Initial diagnosis, and previously unreported cases | Yes | Within 24 hours | LHJ | Both |
Hepatitis C (chronic infection) RST results (See WAC 246-101-200 ) | Providers and facilities performing hepatitis C (chronic infection) RST shall report as a laboratory and comply with the requirements of WAC 246-101-201 through 246-101-230. | |||
Hepatitis D (acute and chronic infection) | Yes | Within 24 hours | LHJ | Both |
Hepatitis E (acute infection) | Yes | Within 24 hours | LHJ | Both |
Herpes simplex, neonatal and genital (initial infection only) | Within 3 business days | LHJ | Providers | |
Histoplasmosis | Within 3 business days | LHJ | Both | |
Human immunodeficiency virus (HIV) infection | Within 3 business days | LHJ | Both | |
Human immunodeficiency virus (HIV) infection RST results (See WAC 246-101-200 ) | Providers and facilities performing HIV infection RST shall report as a laboratory and comply with the requirements of WAC 246101-201 through 246-101-230. | |||
Human prion disease | Within 3 business days | LHJ | Both | |
Hypersensitivity pneumonitis, occupational | Within 30 days | L&I | Both | |
Influenza, novel or unsubtypable strain | Immediately | LHJ | Both | |
Influenza-associated death (laboratory confirmed) | Yes | Within 3 business days | LHJ | Both |
Legionellosis | Within 24 hours | LHJ | Both | |
Leptospirosis | Within 24 hours | LHJ | Both | |
Listeriosis | Within 24 hours | LHJ | Both | |
Lyme disease | Within 3 business days | LHJ | Both | |
Lymphogranuloma venereum | Within 3 business days | LHJ | Both | |
Malaria | Within 3 business days | LHJ | Both | |
Measles (rubeola) - Acute disease only | Immediately | LHJ | Both | |
Melioidosis (Burkholderia pseudomallei ) | Yes | Immediately | LHJ | Both |
Meningococcal disease, invasive | Immediately | LHJ | Both | |
Monkeypox | Immediately | LHJ | Both | |
Mumps, acute disease only | Within 24 hours | LHJ | Both | |
Outbreaks and suspected outbreaks | Immediately | LHJ | Both | |
Paralytic shellfish poisoning | Immediately | LHJ | Both | |
Pertussis | Within 24 hours | LHJ | Both | |
Pesticide poisoning (hospitalized, fatal, or cluster) | Immediately | DOH | Both | |
Pesticide poisoning (all other) | Within 3 business days | DOH | Both | |
Plague | Immediately | LHJ | Both | |
Poliomyelitis | Immediately | LHJ | Both | |
Pregnancy in patient with hepatitis B virus | See "Hepatitis B, report pregnancy in hepatitis B virus infected patients (including carriers)" | |||
Psittacosis | Within 24 hours | LHJ | Both | |
Q fever | Within 24 hours | LHJ | Both | |
Rabies (suspect or laboratory confirmed human cases and laboratory confirmed animal cases) | Yes for animal cases | Immediately | LHJ | Both |
Rabies, suspected human exposure (suspected human rabies exposures due to a bite from or other exposure to an animal that is suspected of being infected with rabies) | Immediately | LHJ | Both | |
Relapsing fever (borreliosis) | Within 3 business days | LHJ | Both | |
Rickettsia infection | Within 3 business days | LHJ | Both | |
Rubella, acute disease only (including congenital rubella syndrome) | Immediately | LHJ | Both | |
Salmonellosis | Within 24 hours | LHJ | Both | |
Serious adverse reactions to immunizations | Within 3 business days | LHJ | Both | |
Shiga toxin-producing E. coli (STEC) infections/enterohemorrhagic E. coli infections | Yes | Immediately | LHJ | Both |
Shigellosis | Within 24 hours | LHJ | Both | |
Silicosis | Within 30 days | L&I | Both | |
Smallpox | Immediately | LHJ | Both | |
Syphilis | Within 3 business days | LHJ | Both | |
Taeniasis | Within 3 business days | LHJ | Both | |
Tetanus | Within 3 business days | LHJ | Both | |
Tick paralysis | Within 3 business days | LHJ | Both | |
Trichinosis | Within 3 business days | LHJ | Both | |
Tuberculosis disease (confirmed or highly suspicious, i.e., initiation of empiric treatment) | Within 24 hours | LHJ | Both | |
Tularemia | Immediately | LHJ | Both | |
Typhus | Within 3 business days | LHJ | Both | |
Vaccinia transmission | Immediately | LHJ | Both | |
Vancomycin-resistant Staphylococcus aureus (not to include vancomycin-intermediate) | Yes | Within 24 hours | LHJ | Both |
Varicella-associated death | Within 3 business days | LHJ | Both | |
Vibriosis (Vibrio species not including Vibrio cholerae O1 or O139) See Cholera (Vibrio cholerae O1 or O139) | Yes | Within 24 hours | LHJ | Both |
Viral hemorrhagic fever | Immediately | LHJ | Both | |
Yellow fever | Immediately | LHJ | Both | |
Yersiniosis | Within 24 hours | LHJ | Both | |
Unexplained critical illness or death | Within 24 hours | LHJ | Both | |
Wash. Admin. Code § 246-101-101